Is HIPEC Beneficial in Platinum Resistant Relapsed Ovarian Cancer?

Romanian Journal of Medical Practice

doi 10.37897/rjmp.2019.3.8

Full Text

Abstract

Available in

Date

September 30, 2019

Authors

Nicolae Bacalbasa

Publisher

AMALTEA Medical Publishing House

Related search

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Value in Health

Occupational Health

English

Oral Melphalan as a Treatment for Platinum-Resistant Ovarian Cancer

British Journal of Cancer

Cancer Research

English

Targeted Treatment of Recurrent Platinum-Resistant Ovarian Cancer: Current and Emerging Therapies

Cancer Management and Research

English

The Use of Treosulfan and Gemcitabine in the Treatment of Platinum-Resistant Ovarian Cancer

Oncology Letters

Cancer Research

English

Emerging Role for Bevacizumab in Combination With Chemotherapy for Patients With Platinum-Resistant Ovarian Cancer

Journal of Clinical Oncology

Cancer Research

English

Prophylactic Mastectomy for BRCA Mutation Carriers After Ovarian Cancer Treatment: Is It Beneficial?

Expert Review of Anticancer Therapy

English

Increased Expression of Annexin A3 Is a Mechanism of Platinum Resistance in Ovarian Cancer

Cancer Research

Cancer Research

English

TCRP1 Expression Is Associated With Platinum Sensitivity in Human Lung and Ovarian Cancer Cells

Oncology Letters

Cancer Research

English

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Clinical Medicine Insights: Oncology

English